about
Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant RecipientsHematopoietic microRNA-126 protects against renal ischemia/reperfusion injury by promoting vascular integrity.Clinical-Grade Isolated Human Kidney Perivascular Stromal Cells as an Organotypic Cell Source for Kidney Regenerative Medicine.Acute Rejection After Kidney Transplantation Associates With Circulating MicroRNAs and Vascular InjuryTransplanting the elderly: Balancing aging with histocompatibility.Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipientsEffect of vascular endothelial growth factor and its receptor KDR on the transendothelial migration and local trafficking of human T cells in vitro and in vivo.Early systemic microvascular damage in pigs with atherogenic diabetes mellitus coincides with renal angiopoietin dysbalance.Mesenchymal stromal cells in renal ischemia/reperfusion injury.Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study.Simultaneous pancreas-kidney transplantation in patients with type 1 diabetes reverses elevated MBL levels in association with MBL2 genotype and VEGF expression.Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Fourth Meeting: lessons learned from first clinical trials.Pre-existing endothelial cell activation predicts vasoplegia after mitral valve surgery.Mesenchymal stromal cell therapy for cardio renal disorders.Donor pre-treatment in clinical kidney transplantation: a critical appraisal.Mesenchymal stromal cells to prevent fibrosis in kidney transplantation.Clinical translation of multipotent mesenchymal stromal cells in transplantation.Incidence of Malignancies in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Diagnosed Between 1991 and 2013.Human Bone Marrow- and Adipose Tissue-derived Mesenchymal Stromal Cells are Immunosuppressive In vitro and in a Humanized Allograft Rejection Model.Association of kidney function with changes in the endothelial surface layer.Mesenchymal Stromal Cell Therapy for Solid Organ Transplantation.Human Allogeneic Bone Marrow and Adipose Tissue Derived Mesenchymal Stromal Cells Induce CD8+ Cytotoxic T Cell Reactivity.Mesenchymal stromal cells in clinical kidney transplantation: how tolerant can it be?NK Cells and MSCs: Possible Implications for MSC Therapy in Renal Transplantation.Alemtuzumab Induction and Delayed Acute Rejection in Steroid-Free Simultaneous Pancreas-Kidney Transplant Recipients.Early Conversion to Prednisolone/Everolimus as an Alternative Weaning Regimen Associates With Beneficial Renal Transplant Histology and Function: The Randomized-Controlled MECANO Trial.The Dutch Transplantation in Vasculitis (DUTRAVAS) Study: Outcome of Renal Transplantation in Antineutrophil Cytoplasmic Antibody-associated Glomerulonephritis.A Novel Clinical Grade Isolation Method for Human Kidney Perivascular Stromal CellsRenal ischemia-reperfusion induces a dysbalance of angiopoietins, accompanied by proliferation of pericytes and fibrosis.Vascular endothelial growth factor-induced signaling pathways in endothelial cells that mediate overexpression of the chemokine IFN-gamma-inducible protein of 10 kDa in vitro and in vivo.The human kidney capsule contains a functionally distinct mesenchymal stromal cell population.Local delivery of liposomal prednisolone leads to an anti-inflammatory profile in renal ischaemia-reperfusion injury in the rat.Twelve tips for developing and delivering a massive open online course in medical education.Kidney injury molecule-1 staining in renal allograft biopsies 10 days after transplantation is inversely correlated with functioning proximal tubular epithelial cells.Expression patterns of vascular endothelial growth factor in human cardiac allografts: association with rejection.Renal ischemia-reperfusion induces release of angiopoietin-2 from human grafts of living and deceased donors.No indications for platelet activation in acute clinical myocardial or renal ischemia/reperfusion injury.Introducing the innovative technique of 360° virtual reality in kidney transplant education.Advancement of Mesenchymal Stem Cell Therapy in Solid Organ Transplantation (MISOT)Circulating MicroRNAs Associate With Diabetic Nephropathy and Systemic Microvascular Damage and Normalize After Simultaneous Pancreas-Kidney Transplantation
P50
Q26799916-B8FE960B-AFB0-460F-BCE1-3A7A77821F02Q30585385-EF7F7E46-4183-448D-BE32-DA18B401AAA9Q33722487-90FC1300-0240-440A-9984-344AA6E098A7Q33874015-BF9B072C-4E4A-44DA-A985-F1CEE5497B83Q34495912-FC64BDB6-3C5E-4A89-B7CB-1F80A37B1BE4Q34753440-C7916C72-F96E-4684-98B0-1D12E7266F98Q35215426-4B8844EF-E2D5-4EC6-94F0-A3EFB518E9DCQ35536459-4B3E7F3D-D9AB-4356-9F0F-32703D898DEBQ36070565-33624B9B-5E09-442F-8775-D9594E6EC1F4Q36246918-B89AE2D5-72AF-4D9D-8E64-9BAD3BC8C021Q36653992-EE5AF8B7-F9EE-488B-A9E6-F74B85F635EBQ37079961-40DF6BF8-A6C9-4ED0-93CE-6E4124BEE6C5Q37099211-DFEB4546-7F1D-4644-BF34-16985DBFFC8FQ38120818-82E7A018-1321-4EC6-A870-DB6AB317F002Q38152775-44C3C6F0-A371-4967-A701-12B60E2F77E3Q38166193-5E75588A-6DB8-46E3-A5BB-AC3068968803Q38248786-7D26E165-48E5-4D96-ABA1-898C434C1F2EQ38413238-5FF3DBE2-FC68-45A6-8808-2EB75D6E2930Q38439453-43A1E637-E84D-4468-B1A3-3EA01FED25E1Q38602892-D75A3281-F696-4E36-8F14-B0DC87562C8CQ38658163-2E58E536-396A-4954-BAAA-4A58FB0FA39FQ38688638-7C737934-E4EA-47F5-B4F3-46F29111A9E8Q38984231-D9AC3DDC-60F9-4EA0-B6DC-1B46D918D766Q40133843-5F9E6E8C-95A1-400B-A9A4-C43CCEF63AABQ40270917-A4E2AD2F-B508-40BD-B133-2183B6F493ADQ40505344-6DFD5AEE-78A8-489A-ACC3-6B14ACB5908EQ40538375-23A6CEF1-9517-475D-80E2-AABE7E939E35Q42364183-160B6C22-B63A-408C-BA63-AB672E7FDDFEQ44655473-50AF728F-30D2-4EFA-8079-F241F109CFF7Q46956205-39B70661-51FD-4994-BD98-30D20241BAAFQ47107074-6FA4082C-A748-401B-9CEB-31F5B468AD4EQ47677126-8221C6F0-64D9-44D1-A645-6795D4646A3EQ48170917-5E18622F-64D1-4034-AC58-68A6F7F67826Q50089919-BC622E7B-444F-4A59-A1E4-0EE4AD5853EDQ50722679-7E9D0BDA-3360-44AB-A2EB-F19F5058D72CQ50848361-EC88D715-4A0B-46B5-B3B6-C514B167BB7CQ52325694-FC3746D0-2DD8-467F-A3BB-0F3DACC67A1BQ52644201-429A4056-280A-45C0-8347-9CDFA0451803Q57702136-AF7F4B4C-0DC2-4696-939E-4A37E777AD13Q57789543-01D06C46-2495-47F6-997E-77C4434D1690
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-9543-567X
@en
name
Marlies E Reinders
@ast
Marlies E Reinders
@en
Marlies E Reinders
@nl
type
label
Marlies E Reinders
@ast
Marlies E Reinders
@en
Marlies E Reinders
@nl
prefLabel
Marlies E Reinders
@ast
Marlies E Reinders
@en
Marlies E Reinders
@nl
P106
P31
P496
0000-0001-9543-567X